Surrozen, Inc.
Surrozen, Inc.
Your view on SRZNW
Overview
What the company does, where it operates, and who runs it.
About Surrozen, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Craig C. Parker
- Headquarters
- 171 Oyster Point Boulevard, South San Francisco, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Craig C. Parker
- Headquarters
- 171 Oyster Point Boulevard, South San Francisco, CA, US
Surrozen, Inc. is a biotechnology company dedicated to identifying and advancing therapeutic candidates. Their core strategy involves precisely influencing the Wnt signaling pathway to promote the body's natural processes of tissue restoration and regeneration. To achieve this, Surrozen engineers antibodies that target specific tissues, aiming to activate the intrinsic repair systems of the body. These innovative therapies hold promise for a wide range of medical conditions affecting organs such as the intestine, liver, eyes (retina, cornea), lungs, kidneys, inner ear (cochlea), skin, pancreas, and the central nervous system. Among its pipeline assets, SZN-043 is designed to foster the regeneration of liver cells (hepatocytes), thereby enhancing liver function and mitigating fibrosis. Additionally, SZN-1326 is a novel bi-specific human antibody. This agent specifically interacts with Frizzled and LRP receptors, which are abundantly found in intestinal crypts, to directly regulate Wnt signaling within the target intestinal tissue. Established in 2016, Surrozen, Inc. operates from its headquarters in South San Francisco, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Surrozen, Inc., and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Surrozen, Inc.. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Surrozen, Inc.. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Surrozen, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Surrozen, Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Surrozen, Inc. valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Surrozen, Inc., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Surrozen, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Surrozen, Inc.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Surrozen, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Surrozen, Inc.. Press releases and market coverage, newest first.